-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Day One Biopharmaceuticals, Inc. quarterly/annual Revenues history and growth rate from Q3 2023 to Q2 2025.
- Day One Biopharmaceuticals, Inc. Revenues for the quarter ending June 30, 2025 was $33.9M, a 314% increase year-over-year.
- Day One Biopharmaceuticals, Inc. Revenues for the twelve months ending June 30, 2025 was $188M.
- Day One Biopharmaceuticals, Inc. annual Revenues for 2024 was $131M.
- Day One Biopharmaceuticals, Inc. annual Revenues for 2023 was $0.000.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)